America’s fourth-largest Catholic healthcare system performed so-called gender affirming surgeries on 81 children and prescribed puberty blockers or cross-sex hormones to 113 over the past five years, according to a national database launched Tuesday by Do No Harm, which fights identity politics in “medical education, research and clinical practice.”
Read More
The American Academy of Pediatrics (AAP) must explain why it “abandoned its commitment to sound medical judgment” by endorsing puberty blockers, cross-sex hormones and sex change surgeries as treatments for children with gender dysphoria, a group of Republican attorneys general told the organization Tuesday.
Citing the Cass report, a four-year systematic review of transgender medical studies conducted in England, the group of 20 states led by Idaho Attorney General Raúl Labrador, along with the Arizona Legislature, wrote it is “beyond medical debate that puberty blockers are not fully reversible but instead come with serious long-term consequences.” In light of this mounting evidence, as well as the exposure of the World Professional Association for Transgender Health (WPATH) standards as “unreliable and influenced by improper pressures,” the states told APP its 2018 policy statement backing these medical procedures is “misleading and deceptive.”
Read More
Five months before the Food and Drug Administration issued a health warning on puberty blockers widely used off-label to treat minors with gender confusion, undermining a Department of Health and Human Services office that claimed “early gender affirming care is crucial to overall health and well-being,” an FDA leader acknowledged other health concerns.
Pediatric patients exposed to “gonadotropin-releasing hormone agonists,” most with central precocious puberty (CPP) and “a handful … transgender kids using the drugs off-label,” had an “increased risk of depression and suicidality, as well as increased seizure risk,” Division of General Endocrinology clinical team leader Shannon Sullivan told colleagues.
Read More
In a seismic ruling Monday, the UK High Court upheld the British government’s ban on puberty blockers, citing a study that found “very substantial risks and very narrow benefits” of early puberty suppression.
Read More
The U.K.-based Economist speculates that Michigan Democratic Gov. Gretchen Whitmer could save her party from defeat in November if she replaces “doddering” President Biden on the ticket, by nationalizing her Great Lakes State strategy of “relentless targeting of suburban swing voters with simple messages: abortion rights, jobs and infrastructure.”
Voters might ask this scion of a political family, who acted out her motto “get sh*t done” by shutting down in-store gardening sections and in-state travel to second homes to defeat COVID-19, why she’s allegedly forcing counselors to help mentally fragile children “undergo permanent, life-altering medical procedures that many will come to regret.”
Read More
A transgender activist group is pressuring corporations to provide insurance coverage for child sex change drugs and genital surgeries.
The Humans Rights Campaign (HRC) is an LGBTQ+ activist group that champions pediatric sex change interventions such as puberty blockers, cross-sex hormones and sex change surgeries. Since 2002, the HRC has issued their Corporate Equality Index (CEI) survey, which scores corporations based on their commitment to LGBTQ+ activism and adherence to LGBTQ+ ideology; corporations can score up to 100 points if they fulfill all criteria outlined by the HRC.
Read More
The Left’s main smear organ has targeted an openly gay organization and groups of doctors who oppose “gender-affirming care” in efforts to silence opposition to the transgender agenda and drag queen story hours.
The Southern Poverty Law Center released its “Year in Hate and Extremism” report Tuesday, warning about encroaching “theocracy” and an “authoritarian takeover” as part of the “organizational infrastructure … upholding white supremacy in the United States.”
Read More
The World Professional Association for Transgender Health (WPATH) is the leading authority in the field of gender medicine. Its guidance is routinely used by top medical associations in the U.S. and abroad, while its standards of care inform insurance companies’ approach to coverage policies.
But behind closed doors, top WPATH doctors discussed, and at times seemed to challenge, the organization’s own published guidelines for sex change procedures and acknowledged pushing experimental medical interventions that can have devastating and irreversible complications, according to exclusive footage obtained by the Daily Caller News Foundation.
Read More
Major medical associations have remained silent after the results of a four-year review commissioned by the National Health Service (NHS) England undermined their recommendations for giving puberty blockers to children with gender dysphoria
The Cass report, conducted by former Royal College of Pediatrics and Child Health Dr. Hilary Cass and released April 10, found that there is “weak evidence” for offering puberty blockers to children. It concluded that its findings “raise questions about the quality of currently available guidelines” offered by associations like the World Professional Association for Transgender Health (WPATH) and the Endocrine Society, yet neither organization has committed to reviewing their guidelines.
Read More
A Scottish gender clinic for minors announced Thursday that they would no longer be prescribing puberty blockers for patients under the age of 18.
The Sandyford Sexual Health Services to Paediatric Endocrinology, which is the only clinic in Scotland that prescribes puberty blockers for minors, said that it would not be accepting new 16 and 17-year-old patients for hormone therapy until they turn 18, according to the announcement. The clinic cited the National Health Service (NHS) of England’s decision in March to ban puberty blockers for minors and the publication of the Cass Review on April 10, which found “weak evidence” for giving puberty blockers to children.
Read More